Trial Profile
A randomized, double-blind, placebo-controlled, multiple-dose, dose-escalation study to assess safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- 09 Feb 2016 New trial record